During the past decade, traditional systems of medicine have become a topic of global importance. Current estimates suggest that, in many developing countries, a large proportion of the population relies heavily on traditional practitioners and medicinal plants to meet primary health care needs. At the same time, many people in developed countries have begun to turn to alternative or complementary therapies, including medicinal herbs.
With 80% of prescriptions filled in the USA being generic drugs, the use of generic drugs is expected to grow over the next few years. With high manufacturing costs in US, generic drug manufacturers should expand their manufacturing base to countries such as India, China and other South East Asian countries which provide high cost advantage. Such a move would also help them in supplying their drugs at a competitive cost.